2407 — Gaush Meditech Balance Sheet
0.000.00%
- HK$1.30bn
- HK$1.41bn
- CNY1.43bn
- 90
- 79
- 78
- 97
Annual balance sheet for Gaush Meditech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 308 | 609 | 814 | 833 | 519 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 173 | 172 | 169 | 149 | 168 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 749 | 1,090 | 1,326 | 1,391 | 1,151 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31.9 | 85.5 | 127 | 126 | 124 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,236 | 2,427 | 2,718 | 2,844 | 2,566 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,281 | 441 | 493 | 892 | 512 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,210 | 3,083 | 1,249 | 1,163 | 991 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 25.6 | -656 | 1,470 | 1,680 | 1,575 |
| Total Liabilities & Shareholders' Equity | 2,236 | 2,427 | 2,718 | 2,844 | 2,566 |
| Total Common Shares Outstanding |